Novartis in Ireland
around the world. We also host international talent here at Ringaskiddy building on their experience and in turn benefiting from a greater diversity of ideas.
“The Novartis workforce in Ringaskiddy has a good reputation as a talent pool throughout the Novartis global family. This is due to the good Irish education system and the professional programmes we have on location here at Novartis.”
Novartis places a strong emphasis on the value of Its proactive approach in helping form the talent pool of the future is a visionary, and yet pragmatic one. Novartis is a leading employer in Ireland, with a total workforce of more than 1,600 highly skilled people across its manufacturing facilities in Ringaskiddy and Model Farm Road Cork, and in its commercial operations, which are located in Dublin.
In Cork, the Novartis Ringaskiddy campus is home to two Novartis organisations — Novartis Ringaskiddy Limited ( NRL) as well as Novart i s International Pharmaceutical Ltd Branch Ireland (NIPBI).
Operational since 1994 NRL manufactures active pharmaceutical ingredients ( API) for a range of oncology, respiratory cardiovascular, dermatology, central nervous systems and transplantation medicines.
The €850m facility in Ringaskiddy includes manufacturing operations, quality control laboratories and warehouse, technical, IT and engineering facilities.
Established in 1998, Novartis International Pharmaceutical Ltd., Branch Ireland (NIPBI) is a global service centre employing approximately 200 people offering technical and business services through a number of functions including External Supply Operation, International Service Laboratory, Supply Chain, Procurement, Finance and Strategy.
Also based in Cork and employing some 500 people, is the Alcon facility on the
Novartis has been making medicine since 1994 at its API manufacturing facility in Ringaskiddy.
During June, Novartis Ringaskiddy welcomed Steffen Lang, head of Novartis technical operations, to Ireland; Steffen is pictured with Joe Garvin, head of production, and Dorothea Ledergerber site head, Novartis Ringaskiddy Limited.
Picture: Clare Keogh